Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Isoray, Inc. | v455807_8k.htm |
Exhibit 10.1
ADDENDUM No. 1
to Contract No. 840/08625142/25/158-15
dtd. December 07, 2015
| Moscow | December 09, 2016 |
JSC “Isotope”, Pogodinskaja, 22, Moscow, 119435 Russia hereinafter named to as “the Sellers’’, and The Company IsoRay Medical Inc., 350 Hills Street, Suite 106, Richland, WA 99354-5411 USA, hereinafter named to as “the Buyers” concluded the present Addendum about the following:
| 1. | To prolong the terms of validity of the present contract till the 31st of December 2017. |
| 2. | To deliver additionally under present contract [**] lots of Cs-131 with activity of [**] Ci each. |
| 3. | The sum of the contract [**]. |
| 4. | The present addendum is the integral part of contract 840/08625142/25/158-15 and may be signed by E-mail. |
| 5. | All the rest terms of Contract No. 840/08625142/25/158-15 remain unchanged. |
| THE SELLERS | THE BUYERS | ||
| /s/ B.V. Aakaiev | /s/ Thomas C. LaVoy | ||
| B.V. Aakaiev | Thomas C. LaVoy | ||
| Director General, JSC “Isotope” | CEO – IsoRay Medical Inc. | ||
| 22.12.16 | December 14, 2016 |
[**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.